nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—urine—bipolar disorder	0.102	0.23	CbGeAlD
Dabigatran etexilate—F2—blood plasma—bipolar disorder	0.0532	0.12	CbGeAlD
Dabigatran etexilate—CES2—adrenal cortex—bipolar disorder	0.0301	0.0679	CbGeAlD
Dabigatran etexilate—NQO2—adrenal cortex—bipolar disorder	0.0269	0.0607	CbGeAlD
Dabigatran etexilate—CES2—thyroid gland—bipolar disorder	0.021	0.0473	CbGeAlD
Dabigatran etexilate—NQO2—thyroid gland—bipolar disorder	0.0187	0.0423	CbGeAlD
Dabigatran etexilate—CES2—nervous system—bipolar disorder	0.0176	0.0398	CbGeAlD
Dabigatran etexilate—CES1—thyroid gland—bipolar disorder	0.0173	0.0389	CbGeAlD
Dabigatran etexilate—CES2—cerebellum—bipolar disorder	0.0166	0.0374	CbGeAlD
Dabigatran etexilate—F2—nervous system—bipolar disorder	0.0158	0.0357	CbGeAlD
Dabigatran etexilate—NQO2—nervous system—bipolar disorder	0.0158	0.0355	CbGeAlD
Dabigatran etexilate—NQO2—cerebellum—bipolar disorder	0.0148	0.0334	CbGeAlD
Dabigatran etexilate—CES1—nervous system—bipolar disorder	0.0145	0.0328	CbGeAlD
Dabigatran etexilate—CES2—brain—bipolar disorder	0.0135	0.0304	CbGeAlD
Dabigatran etexilate—F2—brain—bipolar disorder	0.0121	0.0273	CbGeAlD
Dabigatran etexilate—NQO2—brain—bipolar disorder	0.012	0.0272	CbGeAlD
Dabigatran etexilate—ABCB1—blood plasma—bipolar disorder	0.0114	0.0258	CbGeAlD
Dabigatran etexilate—CES1—brain—bipolar disorder	0.0111	0.025	CbGeAlD
Dabigatran etexilate—ABCB1—adrenal cortex—bipolar disorder	0.0058	0.0131	CbGeAlD
Dabigatran etexilate—UGT2B15—Biological oxidations—COMT—bipolar disorder	0.00415	0.00746	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—MAOA—bipolar disorder	0.00412	0.0074	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC5A3—bipolar disorder	0.0041	0.00737	CbGpPWpGaD
Dabigatran etexilate—ABCB1—thyroid gland—bipolar disorder	0.00404	0.00912	CbGeAlD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—INS—bipolar disorder	0.00388	0.00697	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—CLOCK—bipolar disorder	0.00372	0.00668	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NR1D1—bipolar disorder	0.0037	0.00665	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CLOCK—bipolar disorder	0.00364	0.00654	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—IMPA2—bipolar disorder	0.00355	0.00638	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—MTHFR—bipolar disorder	0.00353	0.00633	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—INS—bipolar disorder	0.00345	0.00619	CbGpPWpGaD
Dabigatran etexilate—ABCB1—nervous system—bipolar disorder	0.0034	0.00767	CbGeAlD
Dabigatran etexilate—CES1—NRF2 pathway—NRG1—bipolar disorder	0.00337	0.00605	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00337	0.00605	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.00335	0.00601	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SERPINA1—bipolar disorder	0.00334	0.00601	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Phase II conjugation—COMT—bipolar disorder	0.00323	0.00581	CbGpPWpGaD
Dabigatran etexilate—ABCB1—cerebellum—bipolar disorder	0.0032	0.00722	CbGeAlD
Dabigatran etexilate—F2—G alpha (q) signalling events—TACR1—bipolar disorder	0.00313	0.00562	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—TACR1—bipolar disorder	0.00309	0.00555	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00301	0.00541	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TRPC3—bipolar disorder	0.00295	0.00529	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00294	0.00528	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC6A4—bipolar disorder	0.00284	0.00511	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—INS—bipolar disorder	0.0028	0.00504	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—MTHFR—bipolar disorder	0.0028	0.00503	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.0028	0.00503	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SERPINA1—bipolar disorder	0.00272	0.00488	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—POMC—bipolar disorder	0.00268	0.00482	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Phase II conjugation—COMT—bipolar disorder	0.00263	0.00472	CbGpPWpGaD
Dabigatran etexilate—ABCB1—brain—bipolar disorder	0.0026	0.00586	CbGeAlD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINA1—bipolar disorder	0.00257	0.00462	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—bipolar disorder	0.00257	0.00462	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—ADM—bipolar disorder	0.00257	0.00461	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—TAC1—bipolar disorder	0.00255	0.00458	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC6A3—bipolar disorder	0.00253	0.00455	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—TAC1—bipolar disorder	0.00252	0.00452	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CLOCK—bipolar disorder	0.00251	0.00451	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—HTR2C—bipolar disorder	0.0025	0.00449	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—IMPA1—bipolar disorder	0.0024	0.00431	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC6A4—bipolar disorder	0.00231	0.00415	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00228	0.0041	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD5—bipolar disorder	0.00224	0.00402	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00224	0.00402	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—INS—bipolar disorder	0.00223	0.004	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—DGKH—bipolar disorder	0.00219	0.00393	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—bipolar disorder	0.00212	0.0038	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—bipolar disorder	0.00209	0.00376	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00207	0.00372	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00207	0.00372	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC6A3—bipolar disorder	0.00206	0.0037	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NDUFV2—bipolar disorder	0.00204	0.00366	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKR1C4—bipolar disorder	0.00198	0.00355	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—NRG1—bipolar disorder	0.00194	0.00348	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—COMT—bipolar disorder	0.00189	0.0034	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—MAOA—bipolar disorder	0.00188	0.00337	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—COMT—bipolar disorder	0.00186	0.00335	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NR1D1—bipolar disorder	0.00177	0.00319	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00172	0.00308	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NCAN—bipolar disorder	0.0017	0.00305	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00169	0.00303	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SLC5A3—bipolar disorder	0.00166	0.00299	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—bipolar disorder	0.00166	0.00299	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00166	0.00298	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00166	0.00298	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.00164	0.00295	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ADM—bipolar disorder	0.00162	0.00291	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—IMPA2—bipolar disorder	0.00162	0.00291	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.0016	0.00288	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—HLA-E—bipolar disorder	0.0016	0.00288	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—TSHB—bipolar disorder	0.00158	0.00284	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—TACR1—bipolar disorder	0.00158	0.00284	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—NRG1—bipolar disorder	0.00157	0.00282	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00156	0.0028	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—COMT—bipolar disorder	0.00154	0.00276	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00153	0.00276	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—MAOA—bipolar disorder	0.00153	0.00274	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TRPC3—bipolar disorder	0.00152	0.00273	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—COMT—bipolar disorder	0.00152	0.00272	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.00147	0.00265	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00145	0.00261	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DGKH—bipolar disorder	0.00138	0.00249	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00137	0.00247	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINA1—bipolar disorder	0.00133	0.00238	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—IMPA2—bipolar disorder	0.00131	0.00236	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR1A—bipolar disorder	0.00131	0.00235	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—TAC1—bipolar disorder	0.00129	0.00231	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD5—bipolar disorder	0.00127	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR2C—bipolar disorder	0.00126	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD1—bipolar disorder	0.00126	0.00227	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DGKH—bipolar disorder	0.00126	0.00226	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—RGS4—bipolar disorder	0.00124	0.00223	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—POMC—bipolar disorder	0.00122	0.0022	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD3—bipolar disorder	0.00122	0.0022	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—POMC—bipolar disorder	0.00121	0.00217	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CLOCK—bipolar disorder	0.0012	0.00216	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD4—bipolar disorder	0.00119	0.00213	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—TSHB—bipolar disorder	0.00117	0.0021	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—TPH2—bipolar disorder	0.00117	0.0021	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CACNB2—bipolar disorder	0.00117	0.0021	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—DPYD—bipolar disorder	0.00115	0.00207	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD5—bipolar disorder	0.00115	0.00207	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—GATA3—bipolar disorder	0.00113	0.00203	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RGS4—bipolar disorder	0.00113	0.00203	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—TSHB—bipolar disorder	0.00111	0.00199	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD2—bipolar disorder	0.00111	0.00199	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—IMPA1—bipolar disorder	0.00109	0.00196	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CACNA1C—bipolar disorder	0.00107	0.00193	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00105	0.00189	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3C2A—bipolar disorder	0.00104	0.00188	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00102	0.00183	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000999	0.00179	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—POMC—bipolar disorder	0.000993	0.00178	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TRPC3—bipolar disorder	0.000959	0.00172	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—SNAP25—bipolar disorder	0.000937	0.00168	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NDUFV2—bipolar disorder	0.000929	0.00167	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADM—bipolar disorder	0.000915	0.00164	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKR1C4—bipolar disorder	0.0009	0.00162	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TSHB—bipolar disorder	0.000892	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PDE4B—bipolar disorder	0.000892	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TACR1—bipolar disorder	0.000892	0.0016	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—IMPA1—bipolar disorder	0.000888	0.0016	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TRPC3—bipolar disorder	0.000871	0.00156	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000868	0.00156	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—GSK3A—bipolar disorder	0.000856	0.00154	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADM—bipolar disorder	0.000831	0.00149	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADCY2—bipolar disorder	0.000829	0.00149	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—bipolar disorder	0.000825	0.00148	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000812	0.00146	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TSHB—bipolar disorder	0.00081	0.00145	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TACR1—bipolar disorder	0.00081	0.00145	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PDE4B—bipolar disorder	0.00081	0.00145	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NR1D1—bipolar disorder	0.000808	0.00145	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKR1C4—bipolar disorder	0.000807	0.00145	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—TCF7L2—bipolar disorder	0.000783	0.00141	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR2A—bipolar disorder	0.000774	0.00139	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NCAN—bipolar disorder	0.000773	0.00139	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC5A3—bipolar disorder	0.000757	0.00136	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NDUFV2—bipolar disorder	0.000755	0.00136	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DGKH—bipolar disorder	0.000742	0.00133	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR1A—bipolar disorder	0.000738	0.00133	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKR1C4—bipolar disorder	0.000731	0.00131	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—TAC1—bipolar disorder	0.000727	0.00131	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD1—bipolar disorder	0.000713	0.00128	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2C—bipolar disorder	0.000713	0.00128	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—COMT—bipolar disorder	0.00071	0.00128	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MAOA—bipolar disorder	0.000705	0.00127	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD3—bipolar disorder	0.000691	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD5—bipolar disorder	0.000679	0.00122	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000678	0.00122	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR1A—bipolar disorder	0.00067	0.0012	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD4—bipolar disorder	0.00067	0.0012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RGS4—bipolar disorder	0.000666	0.0012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—TAC1—bipolar disorder	0.00066	0.00119	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NR1D1—bipolar disorder	0.000657	0.00118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD1—bipolar disorder	0.000647	0.00116	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2C—bipolar disorder	0.000647	0.00116	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADCY2—bipolar disorder	0.000631	0.00113	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—bipolar disorder	0.00063	0.00113	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NCAN—bipolar disorder	0.000628	0.00113	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD3—bipolar disorder	0.000627	0.00113	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD2—bipolar disorder	0.000625	0.00112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000621	0.00112	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—POMC—bipolar disorder	0.000618	0.00111	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC5A3—bipolar disorder	0.000615	0.00111	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD4—bipolar disorder	0.000609	0.00109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—IMPA2—bipolar disorder	0.000603	0.00108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000603	0.00108	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MTHFR—bipolar disorder	0.000574	0.00103	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADCY2—bipolar disorder	0.000573	0.00103	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD2—bipolar disorder	0.000567	0.00102	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CLOCK—bipolar disorder	0.000548	0.000984	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TSHB—bipolar disorder	0.000534	0.000959	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—TPH2—bipolar disorder	0.000534	0.000959	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CACNB2—bipolar disorder	0.000534	0.000959	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DPYD—bipolar disorder	0.000525	0.000943	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TRPC3—bipolar disorder	0.000515	0.000924	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADM—bipolar disorder	0.000491	0.000882	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CACNA1C—bipolar disorder	0.000488	0.000877	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDE4B—bipolar disorder	0.000478	0.000859	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TACR1—bipolar disorder	0.000478	0.000859	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TSHB—bipolar disorder	0.000478	0.000859	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3C2A—bipolar disorder	0.000476	0.000854	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—bipolar disorder	0.000459	0.000824	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000457	0.000821	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—INS—bipolar disorder	0.000456	0.00082	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CLOCK—bipolar disorder	0.000445	0.000799	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2A—bipolar disorder	0.000437	0.000786	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—bipolar disorder	0.000435	0.000781	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TSHB—bipolar disorder	0.000434	0.000779	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—TPH2—bipolar disorder	0.000434	0.000779	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CACNB2—bipolar disorder	0.000434	0.000779	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—INS—bipolar disorder	0.000432	0.000777	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DPYD—bipolar disorder	0.000427	0.000766	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SNAP25—bipolar disorder	0.000427	0.000766	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—IMPA1—bipolar disorder	0.000407	0.000732	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2A—bipolar disorder	0.000397	0.000714	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CACNA1C—bipolar disorder	0.000397	0.000712	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR1A—bipolar disorder	0.000396	0.000711	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TAC1—bipolar disorder	0.00039	0.000701	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3C2A—bipolar disorder	0.000387	0.000694	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD1—bipolar disorder	0.000382	0.000687	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2C—bipolar disorder	0.000382	0.000687	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000381	0.000685	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADCY2—bipolar disorder	0.000378	0.000678	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK2—bipolar disorder	0.000372	0.000668	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD3—bipolar disorder	0.00037	0.000665	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GSK3A—bipolar disorder	0.000369	0.000663	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD4—bipolar disorder	0.00036	0.000646	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—bipolar disorder	0.000349	0.000628	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SNAP25—bipolar disorder	0.000347	0.000623	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NDUFV2—bipolar disorder	0.000346	0.000622	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADCY2—bipolar disorder	0.000339	0.000608	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TCF7L2—bipolar disorder	0.000337	0.000606	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKR1C4—bipolar disorder	0.000335	0.000603	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD2—bipolar disorder	0.000335	0.000602	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—COMT—bipolar disorder	0.000323	0.000581	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MAOA—bipolar disorder	0.000321	0.000577	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—bipolar disorder	0.000317	0.00057	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADCY2—bipolar disorder	0.000307	0.000551	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK1—bipolar disorder	0.000303	0.000545	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000303	0.000544	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NR1D1—bipolar disorder	0.000301	0.000541	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000301	0.00054	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—S100B—bipolar disorder	0.000295	0.00053	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NCAN—bipolar disorder	0.000288	0.000518	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC5A3—bipolar disorder	0.000282	0.000507	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—COMT—bipolar disorder	0.000263	0.000472	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—bipolar disorder	0.000261	0.000469	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MAOA—bipolar disorder	0.000261	0.000469	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NRG1—bipolar disorder	0.00026	0.000467	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—bipolar disorder	0.000235	0.000421	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—bipolar disorder	0.000212	0.000381	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—bipolar disorder	0.000209	0.000375	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—bipolar disorder	0.000208	0.000373	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CLOCK—bipolar disorder	0.000204	0.000367	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TSHB—bipolar disorder	0.000199	0.000357	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—TPH2—bipolar disorder	0.000199	0.000357	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CACNB2—bipolar disorder	0.000199	0.000357	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DPYD—bipolar disorder	0.000196	0.000352	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GSK3B—bipolar disorder	0.000189	0.000339	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—bipolar disorder	0.000187	0.000337	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—bipolar disorder	0.000186	0.000335	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CACNA1C—bipolar disorder	0.000182	0.000327	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3C2A—bipolar disorder	0.000177	0.000319	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—bipolar disorder	0.00017	0.000305	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—bipolar disorder	0.000169	0.000303	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SNAP25—bipolar disorder	0.000159	0.000286	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADCY2—bipolar disorder	0.000141	0.000253	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—COMT—bipolar disorder	0.000121	0.000217	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MAOA—bipolar disorder	0.00012	0.000215	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—bipolar disorder	9.74e-05	0.000175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—bipolar disorder	7.79e-05	0.00014	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—bipolar disorder	7.75e-05	0.000139	CbGpPWpGaD
